Bioventus
(NASDAQ) BVS
Bioventus Financials at a Glance
Market Cap
$623.83M
Revenue (TTM)
$568.09M
Net Income (TTM)
$22.73M
EPS (TTM)
$0.33
P/E Ratio
28.26
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$9.07
Volume
5,527
Open
$9.24
Price
$9.07
Volume
5,527
Open
$9.24
Previous Close
$9.26
Daily Range
$9.02 - $9.39
52-Week Range
$5.81 - $9.56
Dividend
$0.00
Beta (Volatility)
1.16 (Average)
Price
$9.07
Volume
5,527
Open
$9.24
Previous Close
$9.26
Daily Range
$9.02 - $9.39
52-Week Range
$5.81 - $9.56
BVS News
BVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bioventus
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
930
CEO
Robert Claypoole, MBA
Website
www.bioventus.comHeadquarters
Durham, NC 27703, US
BVS Financials
Key Financial Metrics (TTM)
Gross Margin
67%
Operating Margin
10%
Net Income Margin
4%
Return on Equity
14%
Return on Capital
11%
Return on Assets
3%
Earnings Yield
3.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$623.83M
Shares Outstanding
67.37M
Volume
5.53K
Short Interest
0.00%
Avg. Volume
323.91K
Financials (TTM)
Gross Profit
$382.43M
Operating Income
$58.55M
EBITDA
$105.56M
Operating Cash Flow
$73.98M
Capital Expenditure
$2.56M
Free Cash Flow
$71.41M
Cash & ST Invst.
$51.24M
Total Debt
$311.35M
Bioventus Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$157.90M
+2.8%
Gross Profit
$104.45M
+1.8%
Gross Margin
66.15%
N/A
Market Cap
$623.83M
N/A
Market Cap/Employee
$670.78K
N/A
Employees
930
N/A
Net Income
$14.76M
+9558.3%
EBITDA
$37.49M
+73.3%
Quarterly Fundamentals
Net Cash
$260.11M
+11.5%
Accounts Receivable
$128.30M
+0.7%
Inventory
$82.24M
-11.1%
Long Term Debt
$292.14M
-5.2%
Short Term Debt
$19.21M
-29.7%
Return on Assets
3.33%
N/A
Return on Invested Capital
10.91%
N/A
Free Cash Flow
$37.39M
+99.4%
Operating Cash Flow
$37.97M
+96.5%